Search Medicines & Medical Devices

Curated Report Builder

Select medicine rows from results below to preview a paid report. Quote is based on selected items.

View Plans
Sign in to unlock report generation

Medicine results for "ESTRADIOL VALERATE" 12 medicines

Price column visibility: locked (sign in required)

Page 1 of 1

ESTRADIOL VALERATE +NORETHINDRONE ENANTHATE

Uganda
NDA/MAL/HDP/4187
Details

Estradiol valerate

Nigeria
Oestrafert 2 mg Drugs
Details

Estradiol valerate

Nigeria
Progynova 2 mg Tablet Drugs
Details

PROGYNOVA

Kenya
1963 ESTRADIOL VALERATE
Details

QLAIRA

Kenya
H2012/CTD526/431/R1 Estradiol valerate and Dienogest
Details

QLAIRA TABLETS

Ghana
FDA/SD.255-122211 Estradiol valerate/Dienogest
Details

NORIGYNON

Rwanda
Rwanda FDA-HMP-MA-1561 Estradiol valerate Norethisterone enantate
Details

PROGYNOVA​ TABLETS 2mg

Ghana
FDA/SD.253-040639 Estradiol valerate
Details

Norigynon

Tanzania
TAN 00,4244 G03A N.V Estradiol valerate 5 mg/5.26ml,Norethisterone Enantate 50 mg/5.26ml
Details

DENOPAUS 1 mg/2 mg

South Africa
57/21.8.2/0516 ESTRADIOL VALERATE EQUIVALENT TO ESTRADIOL , DIENOGEST
Details

NORIGYNON 1% INJECTION -IM

Malawi
PMPB/PL111/18 NORETHISTERONE ENANTHATE, ESTRADIOL VALERATE
Details

Qlaira

Tanzania
TAN 26 HM 0471 Dienogest (Light yellow tablets) 3 mg,Dienogest (medium red tablets) 2 mg,Dienogest, micronized (for Phase 2 of the FPP) 2.000 mg,Dienogest, micronized (for Phase 3 of the FPP) 3.000 mg,Estradiol valerate (Dark red tablets) 1 mg,Estradiol valerate (Light yellow tablets) 2 mg,Estradiol valerate (dark yellow tablets) 3 mg,Estradiol valerate (medium red tablets) 2 mg,Estradiol valerate, micronized (for Phase 1 of the FPP) 3.000 mg,Estradiol valerate, micronized (for Phase 2 of the FPP) 2.000 mg,Estradiol valerate, micronized (for Phase 3 of the FPP) 2.000 mg,Estradiol valerate, micronized (for Phase 4 of the FPP) 1.000 mg,Ferric oxide, red (for Phase 2 of the FPP) 0.03906 mg,Ferric oxide, red (for Phase 4 of the FPP) 0.3651 mg,Ferric oxide, yellow (for Phase 1 of the FPP) 0.2920 mg,Ferric oxide, yellow (for Phase 3 of the FPP) 0.03906 mg,Hypromellose 5 cP (for Phases 1, 2, 3 and 4 of the FPP) 1.5168 mg,Hypromellose 5 cP (for Placebo of the FPP) 1.0112 mg,Lactose monohydrate (for Phase 1 of the FPP) 48.360 mg,Lac
Details